Xing M - Search Results

1

Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.

Alzahrani AS, Qasem E, Murugan AK, Al-Hindi HN, AlKhafaji D, Almohanna M, Xing M, Alhomaidah D, AlSwailem M. Alzahrani AS, et al. Among authors: xing m. Thyroid. 2016 Feb;26(2):235-41. doi: 10.1089/thy.2015.0510. Epub 2016 Jan 21. Thyroid. 2016. PMID: 26711586

2

Mitochondrial DNA alterations in thyroid cancer.

Tong BC, Ha PK, Dhir K, Xing M, Westra WH, Sidransky D, Califano JA. Tong BC, et al. Among authors: xing m. J Surg Oncol. 2003 Mar;82(3):170-3. doi: 10.1002/jso.10202. J Surg Oncol. 2003. PMID: 12619060

3

BRAF mutation in papillary thyroid carcinoma.

Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D. Cohen Y, et al. Among authors: xing m. J Natl Cancer Inst. 2003 Apr 16;95(8):625-7. doi: 10.1093/jnci/95.8.625. J Natl Cancer Inst. 2003. PMID: 12697856

4

Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.

Xing M, Usadel H, Cohen Y, Tokumaru Y, Guo Z, Westra WB, Tong BC, Tallini G, Udelsman R, Califano JA, Ladenson PW, Sidransky D. Xing M, et al. Cancer Res. 2003 May 1;63(9):2316-21. Cancer Res. 2003. PMID: 12727856

5

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

Xing M, Cohen Y, Mambo E, Tallini G, Udelsman R, Ladenson PW, Sidransky D. Xing M, et al. Cancer Res. 2004 Mar 1;64(5):1664-8. doi: 10.1158/0008-5472.can-03-3242. Cancer Res. 2004. PMID: 14996725

6

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.

Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW. Xing M, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2867-72. doi: 10.1210/jc.2003-032050. J Clin Endocrinol Metab. 2004. PMID: 15181070 Clinical Trial.

7

High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.

Vasko V, Hu S, Wu G, Xing JC, Larin A, Savchenko V, Trink B, Xing M. Vasko V, et al. Among authors: xing m, xing jc. J Clin Endocrinol Metab. 2005 Sep;90(9):5265-9. doi: 10.1210/jc.2004-2353. Epub 2005 Jul 5. J Clin Endocrinol Metab. 2005. PMID: 15998781

8

The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.

Xing M. Xing M. Clin Endocrinol (Oxf). 2005 Sep;63(3):263-6. doi: 10.1111/j.1365-2265.2005.02332.x. Clin Endocrinol (Oxf). 2005. PMID: 16117812

9

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW. Xing M, et al. J Clin Endocrinol Metab. 2005 Dec;90(12):6373-9. doi: 10.1210/jc.2005-0987. Epub 2005 Sep 20. J Clin Endocrinol Metab. 2005. PMID: 16174717

10

Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer.

Hu S, Ewertz M, Tufano RP, Brait M, Carvalho AL, Liu D, Tufaro AP, Basaria S, Cooper DS, Sidransky D, Ladenson PW, Xing M. Hu S, et al. Among authors: xing m. J Clin Endocrinol Metab. 2006 Jan;91(1):98-104. doi: 10.1210/jc.2005-1810. Epub 2005 Nov 1. J Clin Endocrinol Metab. 2006. PMID: 16263813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,558 results

Search Page

Filters